Medical News

Long-term Weight Gain After Initiating Combination Antiretro...
Int J Infect Dis

Antiretroviral-therapy-associated weight gain continued to increase for 5 years following treatment initiation. A...

22 Jul 2021

The Predicted Risk of Adverse Pregnancy Outcomes as a Result...
AIDS

Treatment-associated obesity increased the APO risk in women. This risk is likely to increase, as preliminary data...

21 Jul 2021

Association Between Pain, Pulmonary Function, and Respirator...
JAIDS

In PWH, pain is common and associated with airflow obstruction, dyspnea, and sleep disturbance. Future studies...

20 Jul 2021

Trends of Age-related Non-communicable Diseases in People Li...
HIV Med

Although the RR of each NCD in PLWH showed variable trends compared with that in controls, NCDs in PLWH have been...

16 Jul 2021

Key Trials

Safety and Immunogenicity of the ChAdOx1 nCoV-19 Vaccine in People with HIV

The present study evaluated safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine in people with HIV (PLHIV) in a well characterised UK cohort....

AMBER and EMERALD Trial: 96-week Resistance Analysis of Once-daily Single Tablet Regimen of D/C/F/TAF in HIV-1 Adults Patients

The present study is a 96-week resistance analysis of AMBER and EMERALD trials, evaluating efficacy and safety of darunavir/cobicistat/emtricitabine...

Benefits of Inhaled Budesonide in Early COVID-19 Infection: STOIC Study

This infographic summarises the key points of the STOIC study and outlines the benefits of administering inhaled budesonide in early COVID-19...

48-week Efficacy and Safety of Switching to Bictegravir/ Emtricitabine/Tenofovir alafenamide in Virologically Suppressed People Living with HIV aged > 65 years

The presents study evaluated efficacy and safety of switching older people with HIV to bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF)....

Our Publications

Antiretroviral-based Prevention Strategies in HIV

Today, antiretroviral therapy (ART) is not only known to keep HIV-infected patients alive but is also being harnessed as a strategy to prevent...

Antiretroviral Therapy – Current Recommendations

Advances in the treatment of HIV infection has resulted in a dramatic shift, from a deadly infectious disease to a chronic manageable condition....

Datasheet: Lopinavir and Ritonavir (40mg/10mg) Oral Pellets

Lopinavir and Ritonavir (40 mg / 10 mg) Oral Pellets is a Novel oral pellet formulation for paediatric use. This datasheet contains the entire...

Fast Facts: Lopinavir and Ritonavir (40 mg/10 mg) Oral Pellets

Lopinavir and Ritonavir (40 mg / 10 mg) Oral Pellets is a Novel oral pellet formulation for paediatric use. This booklet contains information about...

Patient Education

Live Healthier, Live Longer

This publication features commonly asked questions by HIV patients regarding HIV therapy, drug side-effects, Do’s and Don’ts while on HIV treatment....

Living with Hope

This publication features common questions which arise in HIV patients mind regarding HIV, diagnosis, transmission, treatment and drug side effects. ...

Slide Library

HIV - HCV Coinfection

This slide set covers the epidemiology, disease progression and management of HIV-HCV coinfection in the era of directly acting antivirals available...

 
Email this page
HIV - Pre-exposure Prophylaxis (PrEP): Guidance on PrEP Use

PrEP is the use of an antiretroviral medication by HIV-negative individuals to prevent them from acquiring HIV. These slides give an overview on the...

 
Email this page
HIV- Post-exposure Prophylaxis (PEP)

Post-exposure prophylaxis (PEP) is the method of preventing exposures of HIV to blood and body fluids and it is considered to be the most important...

 
Email this page
Isoniazid Preventive Therapy in HIV Infection

HIV is the strongest risk factor for developing tuberculosis (TB) disease in those with latent or new Mycobacterium tuberculosis infection....

 
Email this page

Poll

Which is your preferred 3rd drug in a first-line regimen?

Efavirenz 600
50% (3 votes)
Efavirenz 400
17% (1 vote)
Dolutegravir
33% (2 votes)
Total votes: 6